Company Overview
American HealthCare Capital is pleased to exclusively introduce a Medicare certified Home Health Agency for sale in Southern California. The Company was incorporated in 2014 and became Medicare certified and ACHC accredited in September 2016. They focus exclusively on skilled home health services, providing high-quality, compassionate care to patients recovering from illness, injury, or surgery in the comfort of their homes.
The agency is based in Orange County, and its service area includes Orange, Los Angeles, San Diego, San Bernardino, and Riverside Counties, allowing them to broad access to one of the most densely populated and demographically favorable regions in the state.
Payer Mix, Census & Referrals
The Company’s payer mix is heavily weighted toward Medicare, providing stable and reliable reimbursement. Medicare comprises 88% of the business, while other payers make up the remaining 12%.
The agency maintains a robust and stable average daily census of 192 patients, including 169 Medicare and 23 from other payers. Referrals are received from a diverse network of physicians, hospitals, and health systems that continues to drive consistent admissions and census growth.
Financial Overview
The Company has demonstrated consistent revenue and profitability over the past several years. Gross revenue was nearly $3.2 million in 2024 and is expected to be approximately $2.8 million in 2025 with a net income near $800,000. The slight dip in revenue is due to the company’s focus on implementing operational efficiencies to improve the net income margin.
Growth Opportunities
There are several avenues for continued growth, including expanding referral partnerships and increasing penetration within the existing service area. Given its established compliance record, strong brand reputation, and scalable structure, the Company is well positioned for expansion under new ownership.
Staff Overview
The Company employs a total of 39 staff, including full time, part time, and per diem clinicians and admin staff. The owner currently serves as CEO, but the leadership and clinical teams are capable of maintaining operations post-transaction, offering a smooth transition for a new owner.
Asking Price
The asking price for this opportunity is $2.8 million, which does not include cash, receivables, or working capital.
